These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10888702)

  • 1. Evidence-based treatment of systemic vasculitis.
    Jayne D
    Rheumatology (Oxford); 2000 Jun; 39(6):585-95. PubMed ID: 10888702
    [No Abstract]   [Full Text] [Related]  

  • 2. ANCA-positive vasculitis.
    Kamesh L; Harper L; Savage CO
    J Am Soc Nephrol; 2002 Jul; 13(7):1953-60. PubMed ID: 12089393
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory vasculitis.
    Rutgers A; Kallenberg CG
    Autoimmun Rev; 2011 Sep; 10(11):702-6. PubMed ID: 21600312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based management of ANCA vasculitis.
    Carruthers D; Sherlock J
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ANCA-positive vasculitis with thyroid disease.
    Rothe HM; Siegmund J; Müller H; Wopperer J
    Nephrol Dial Transplant; 2008 Jun; 23(6):2107; author reply 2107-8. PubMed ID: 18323519
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic vasculitis treatment and monitoring update, 2008.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2008; 66(3):228-30. PubMed ID: 18937637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancytopenia in ANCA associated vasculitis: response to immunosuppressive therapy.
    Letellier E; Cunningham J; Feakins RM; Hughes GR; D'Cruz DP
    Clin Exp Rheumatol; 2003; 21(3):415-6. PubMed ID: 12846080
    [No Abstract]   [Full Text] [Related]  

  • 8. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical management and treatment of vasculitis.
    Jayne D
    Springer Semin Immunopathol; 2001; 23(3):267-86. PubMed ID: 11591102
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis.
    Jones R; Shah S; MacMahon EE; Goldsmith DJ
    Nephrol Dial Transplant; 2003 Sep; 18(9):1920-2. PubMed ID: 12937244
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of therapy for ANCA-associated vasculitis.
    Turnbull J; Harper L
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):391-401. PubMed ID: 19508946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
    Kötter I
    Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CARI guidelines. Induction and maintenance therapy in ANCA-associated systemic vasculitis.
    Menahem S; Hiremagalur B; Mudge D; Toussaint N; Walters G;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S24-36. PubMed ID: 18713121
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolving pathogenesis of systemic vasculitis.
    Savage CO
    Clin Med (Lond); 2002; 2(5):458-64. PubMed ID: 12448596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of rapidly progressive glomerulonephritis.
    Glassock R; Henrich WL
    Hosp Pract (1995); 2000 Feb; 35(2):59-62, 65-6, 69-70; discussion 70-1. PubMed ID: 10689390
    [No Abstract]   [Full Text] [Related]  

  • 19. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Flossmann O; de Groot K
    Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Levine SM
    Ann Intern Med; 2010 Jan; 152(1):65; author reply 65. PubMed ID: 20048281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.